Phaos Technology Holdings (Cayman) (POAS) Other Non-Current Assets (2024 - 2025)
Phaos Technology Holdings (Cayman) (POAS) reported Other Non-Current Assets of $35989.7 for Q2 2025, up 12.07% on a YoY basis from $32112.4 in Q2 2024, and up 12.07% quarter-over-quarter from $32112.4 in Q2 2024.
Phaos Technology Holdings (Cayman) (POAS) Other Non-Current Assets (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) has reported Other Non-Current Assets for 2 years, with the latest figure at $35989.7 in Q2 2025.
- For the quarter ending Q2 2025, Other Non-Current Assets rose 12.07% year-over-year to $35989.7; the trailing twelve-month figure through Apr 2025 stood at $35989.7 (up 12.07% YoY), and the FY2025 full-year result was $36851.0, up 14.76% from the prior year.
- Other Non-Current Assets for Q2 2025 stood at $35989.7, up from $32112.4 in the prior quarter.
- The five-year high for Other Non-Current Assets was $35989.7 in Q2 2025, with the low at $32112.4 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Phaos Technology Holdings (Cayman) | 682,234.12 | 627,245.12 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 35,989.75 |
| Apr 30, 2024 | 32,112.36 |